Person working in pharmacy Drug patents don’t last forever, so pharmaceutical companies are constantly looking for the next big treatment to broaden their total portfolio of offerings. When it was clear a few years ago that biosimilars for AbbVie‘s (NYSE: ABBV) Humira would be hitting the market, management knew it had work to do. Humira […]